View Cart  

U.S. Lawmakers Asked to Better Monitor, Protect Overseas Patents

A A
Congress and the U.S. Trade Representative need to do more to protect American biopharma patents abroad, an intellectual property (IP) expert tells Congress.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00